Group 6 Copy 49
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Probiotics for wild boreal toads facing a deadly fungal disease

    A fungal pathogen spread around the globe by human activities now threatens many amphibians, including boreal...

    Can music influence the longevity of human blood cells?

    Pythagoras believed that music could be used “in the place of medicine”* yet, to our knowledge, this important...

    Backer Badge Funded

    A biology project funded by 47 people